CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a Foreign Private Issuer filed by CollPlant Biotechnologies Ltd. for the month of September 2026. The filing, dated September 18, 2026, serves to distribute an updated corporate presentation to the U.S. Securities and Exchange Commission.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to incorporate an exhibit and does not contain a financial statement or earnings release.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The primary action is the posting of an updated corporate presentation on the company's website on September 17, 2026.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, or contingencies. These details are contained within the attached Exhibit 99.1 (Corporate Presentation), which is incorporated by reference but not summarized in the filing text itself.
Key Facts for Investor Verification
- Verify the contents of the updated Corporate Presentation (Exhibit 99.1) for strategic updates or new data.
- Confirm the filing date of September 18, 2026, and the signature by Eran Rotem, Deputy CEO and CFO.
- Note that this filing contains no standalone financial data; investors must refer to the attached exhibit or other periodic reports for financial metrics.